A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio

Table 2 Comparison of biochemical and hematological characteristics in CAD patients undergoing BMS implantation with and without ISR

	Non-ISR group (n = 243)	ISR group (n = 225)	P
Glucose, mg/dL, mean ± SD	120 ± 46.0	127 ± 52.5	0.11
Creatinine, mg/dL, mean ± SD	0.88 ± 0.26	0.91 ± 0.23	0.11
Total cholesterol, mg/dL, mean ± SD	177 ± 43.2	176 ± 43.1	0.77
Triglyceride, mg/dL	150 ± 77.5	164 ± 84.0	0.06
Low-density lipoprotein, mg/dL, mean ± SD	108 ± 34.9	106 ± 39.0	0.58
High-density lipoprotein, mg/dL, mean ± SD	41.9 ± 11,6	38.4 ± 9.3	<0.001
Uric Acid, mean ± SD	5.2 ± 1.45	5.8 ± 1.48	<0.001
Hemoglobin, g/dL, mean ± SD	13.9 ± 1.68	13.8 ± 3.21	0.76
Platelet, ×10³/L, mean ± SD	259 ± 74.6	267 ± 69.6	0.18
White blood cell, × 10 9 /μl , mean ± SD	7700 ± 1820	9100 ± 1730	<0.001
Neutrophil × 10 9 /μl , mean ± SD	4600 ± 1340	6600 ± 1770	<0.001
Lymphocyte ×10 9 /μl , mean ± SD	2200 ± 680	1700 ± 540	<0.001
Monocyte ×10 9 /μl , mean ± SD	550 ± 250	610 ± 240	0.006
C-reactive protein (mg/dl), mean ± SD	5.8 ± 6.32	8.2 ± 8.79	0.007
Monocyte/ HDL Ratio	14.1 ± 7.17	16.7 ± 7.95	<0.001

CAD coronary artery disease, ISR instent restenosis, BMS bare-metal stent, HDL high-density lipoprotein, SD standart deviation, IQR interquantile range. Bold data displays statisticially significant difference (p<0.05)

ISSN: 1471-2261